Cure as a treatment target in rheumatoid arthritis and systemic sclerosis-achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration
Ann Rheum Dis. 2025 Feb;84(2):153-157.
doi: 10.1136/ard-2024-226772.
Epub 2025 Jan 2.
1 Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK; Rheumatology Department, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
2 Rheumatology and Clinical Immunology, Universitair Medisch Centrum Utrecht, Utrecht, The Netherlands.
3 Novartis, Basel, Switzerland.
4 AbbVie Inc, Cambridge, Massachusetts, USA.
5 UCB, Slough, UK.
6 Pfizer, Collegeville, Pennsylvania, USA.
7 Department of Rheumatology and Clinical Immunology, Charité - Universitätsmedizin Berlin, Berlin, Germany. Electronic address: gerd.burmester@charite.de.